{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:32:12Z","timestamp":1793712732217,"version":"4.6.1"},"reference-count":37,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171055"],"award-info":[{"award-number":["82171055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271085"],"award-info":[{"award-number":["82271085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2024,8,3]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Variants in the <jats:italic>RPGR<\/jats:italic> are the leading cause of X-linked retinopathies (XLRPs). Further in-depth investigation is needed to understand the natural history.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Review of all case records, molecular genetic testing results, best-corrected visual acuity (BCVA), retinal imaging data (including fundus autofluorescence imaging and optical coherence tomography (OCT)), static visual field (VF) assessments and full-field electroretinogram.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Genetic testing was conducted on 104 male patients from 89 family pedigrees, identifying 22 novel variants and 1 de novo variant. The initial symptoms appeared in 78.2% of patients at a median age of 5 years. BCVA declined at a mean rate of 0.02 (IQR, 0\u20130.04) logarithm of the minimum angle of resolution per year, with a gradual, non-linear decrease over the first 40 years. Autofluorescence imaging revealed macular atrophy at a median age of 36.1 (IQR, 29.9\u201343.2) years. Patients experienced blindness at a median age of 42.5 (IQR, 32.9\u201345.2) years according to WHO visual impairment categories. OCT analysis showed a mean ellipsoid zone narrowing rate of 23.3 (IQR, \u22121.04\u201322.29) \u00b5m\/month, with an accelerated reduction in the first 40 years (p&lt;0.01). The median age at which ERG no longer detected a waveform was 26.5 (IQR, 20.5\u201332.8) years. Comparison by variant location indicated faster progression in patients with exon 1\u201314 variants during the initial two decades, while those with ORF15 variants showed accelerated progression from the third decade.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We provide a foundation for determining the treatment window and an objective basis for evaluating the therapeutic efficacy of gene therapy for XLRP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmg-2024-110088","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T13:20:45Z","timestamp":1723900845000},"page":"973-981","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["From onset to blindness: a comprehensive analysis of <i>RPGR<\/i>-associated X-linked retinopathy in a large cohort in China"],"prefix":"10.1136","volume":"61","clinical-trial-number":[{"clinical-trial-number":"nct03116113","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03316560","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04671433","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04312672","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04794101","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05874310","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05874310","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-7490","authenticated-orcid":false,"given":"Jiawen","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daowei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-3386","authenticated-orcid":false,"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingke","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai 200000, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai 200000, China"},{"name":"Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai 200000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"2025101710481121000_61.10.973.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100898"},{"key":"2025101710481121000_61.10.973.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000003920","article-title":"A SYSTEMATIC LITERATURE REVIEW OF DISEASE PROGRESSION REPORTED IN RPGR -ASSOCIATED X-LINKED RETINITIS PIGMENTOSA","volume":"44","author":"Lam","year":"2024","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025101710481121000_61.10.973.3","doi-asserted-by":"publisher","DOI":"10.1038\/78182"},{"key":"2025101710481121000_61.10.973.4","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.5.15","article-title":"Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry","volume":"11","author":"Buckley","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"2025101710481121000_61.10.973.5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20461"},{"key":"2025101710481121000_61.10.973.6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307698"},{"key":"2025101710481121000_61.10.973.7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40123-022-00602-y","article-title":"X-Linked Retinitis Pigmentosa Gene Therapy: Preclinical Aspects","volume":"12","author":"Mansouri","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"2025101710481121000_61.10.973.8","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/hmg\/ddw361","article-title":"Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration","volume":"25","author":"Charng","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2025101710481121000_61.10.973.9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat Med"},{"key":"2025101710481121000_61.10.973.10","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.850122","article-title":"Mutation Analysis of the RPGR Gene in a Chinese Cohort","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"2025101710481121000_61.10.973.11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041280","article-title":"RPGR-Related Retinopathy: Clinical Features, Molecular Genetics, and Gene Replacement Therapy","volume":"13","author":"Awadh Hashem","year":"2023","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025101710481121000_61.10.973.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.038"},{"key":"2025101710481121000_61.10.973.13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ophtha.2022.11.015","article-title":"RP2-Associated X-linked Retinopathy: Clinical Findings, Molecular Genetics, and Natural History","volume":"130","author":"Georgiou","year":"2023","journal-title":"Ophthalmology"},{"key":"2025101710481121000_61.10.973.14","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.5.3.6","article-title":"Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis Pigmentosa","volume":"5","author":"Ramachandran","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"2025101710481121000_61.10.973.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.09.038"},{"key":"2025101710481121000_61.10.973.16","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-017-9621-y"},{"key":"2025101710481121000_61.10.973.17","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0000000000002125"},{"key":"2025101710481121000_61.10.973.18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41433-023-02686-7","article-title":"Prevalence and optical coherence tomography analyses of outer retinal tubulations in Chinese population with inherited retinal diseases","volume":"38","author":"Chen","year":"2024","journal-title":"Eye (Lond)"},{"key":"2025101710481121000_61.10.973.19","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.61.14.36","article-title":"Spectrum of Disease Severity in Patients With X-Linked Retinitis Pigmentosa Due to RPGR Mutations","volume":"61","author":"Di Iorio","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025101710481121000_61.10.973.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085752","article-title":"Novel mutations of RPGR in Chinese retinitis pigmentosa patients and the genotype-phenotype correlation","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"2025101710481121000_61.10.973.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100375","article-title":"Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa","volume":"4","author":"De Silva","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"2025101710481121000_61.10.973.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.10.003"},{"key":"2025101710481121000_61.10.973.23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15013"},{"key":"2025101710481121000_61.10.973.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47251-z","article-title":"Multimodal structural disease progression of retinitis pigmentosa according to mode of inheritance","volume":"9","author":"Jauregui","year":"2019","journal-title":"Sci Rep"},{"key":"2025101710481121000_61.10.973.25","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(93)90072-Y"},{"key":"2025101710481121000_61.10.973.26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives","volume":"63","author":"Dias","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"2025101710481121000_61.10.973.27","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.32"},{"key":"2025101710481121000_61.10.973.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.06.005"},{"key":"2025101710481121000_61.10.973.29","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.2174\/0929867324666170801100516","article-title":"Therapeutic Potential of Co-enzyme Q10 in Retinal Diseases","volume":"24","author":"Zhang","year":"2017","journal-title":"Curr Med Chem"},{"key":"2025101710481121000_61.10.973.30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167546","article-title":"Natural history of retinitis pigmentosa based on genotype, vitamin A\/E supplementation, and an electroretinogram biomarker","volume":"8","author":"Comander","year":"2023","journal-title":"JCI Insight"},{"key":"2025101710481121000_61.10.973.31","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-3557","article-title":"Mechanism and ingredients prediction of Radix Salviae-Angelicae Sinensis Radix-Lycii Fructus-Rehmanniae Radix Praeparata-Ginkgo Folium for retinitis pigmentosa therapy using network pharmacology and molecular docking analysis","volume":"11","author":"Wu","year":"2023","journal-title":"Ann Transl Med"},{"key":"2025101710481121000_61.10.973.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023021","article-title":"Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations","volume":"6","author":"Fahim","year":"2011","journal-title":"PLoS One"},{"key":"2025101710481121000_61.10.973.33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0971"},{"key":"2025101710481121000_61.10.973.34","doi-asserted-by":"publisher","DOI":"10.1086\/379379"},{"key":"2025101710481121000_61.10.973.35","doi-asserted-by":"publisher","DOI":"10.1076\/opge.24.4.215.17228"},{"key":"2025101710481121000_61.10.973.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100975"},{"key":"2025101710481121000_61.10.973.37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.6254"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2024-110088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:48:22Z","timestamp":1760723302000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2024-110088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,9,24]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/jmg-2024-110088"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2024-110088","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]}}}